文献速递肝病消化道肿瘤与早癌

低乙肝病毒与高乙肝病毒/丁肝病毒流行国家所有乙肝携带者的丁型肝炎双重反射检测

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
PubMed 文献 · J Hepatol · 2023-04-06

丁型肝炎病毒(HDV)与乙肝共感染增加肝癌、失代偿肝硬化和死亡风险。作者建议在所有乙肝表面抗原阳性者中先检测抗-HDV,抗-HDV阳性者再检测HDV RNA(双重反射检测),此策略在低HBV流行及高HBV/HDV流行国家均适用。

要点

  • 所有乙肝表面抗原阳性者应检测抗-HDV,抗-HDV阳性者再检测HDV RNA。

核心结论

  • 双重反射检测是在国家层面估计抗-HDV和HDV RNA阳性率并发现未诊断个体的最有效方法。
  • 在低HBV流行国家以及HBV和HDV均高流行国家,双重反射检测是首选策略。

研究设计与样本

  • 本文为综述,基于全球HBV感染估计数据及作者初步估计,提出HDV筛查策略。

主要发现

  • 2021年全球HBV感染估计为262,240,000例,其中仅1,994,000例为新诊断,新诊断中一半以上在中国。
  • 作者初步估计抗-HDV和HDV RNA阳性率远低于已发表研究报告的水平。
  • 全球层面全面HDV筛查策略仅需1,994,000次HDV抗体检测和不足89,000次HDV PCR检测。
  • 欧盟和北美每年分别仅35,000例和22,000例需抗-HDV检测。

关键数值与推荐

  • 对所有乙肝表面抗原阳性个体检测抗-HDV,对所有抗-HDV阳性个体检测HDV RNA。

临床怎么用

  • 在低HBV流行国家及HBV和HDV均高流行国家,作者推荐采用双重反射检测策略。

局限性

  • 作者指出其初步估计的抗-HDV和HDV RNA阳性率远低于已发表研究,需准确的HDV流行率估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatitis D virus (HDV) infection occurs as a coinfection with hepatitis B and increases the risk of hepatocellular carcinoma, decompensated cirrhosis, and mortality compared to hepatitis B virus (HBV) monoinfection. Reliable estimates of the prevalence of HDV infection and disease burden are essential to formulate strategies to find coinfected individuals more effectively and efficiently. The global prevalence of HBV infections was estimated to be 262,240,000 in 2021. Only 1,994,000 of the HBV infections were newly diagnosed in 2021, with more than half of the new diagnoses made in China. Our initial estimates indicated a much lower prevalence of HDV antibody (anti-HDV) and HDV RNA positivity than previously reported in published studies. Accurate estimates of HDV prevalence are needed. The most effective method to generate estimates of the prevalence of anti-HDV and HDV RNA positivity and to find undiagnosed individuals at the national level is to implement double reflex testing. This requires anti-HDV testing of all hepatitis B surface antigen-positive individuals and HDV RNA testing of all anti-HDV-positive individuals. This strategy is manageable for healthcare systems since the number of newly diagnosed HBV cases is low. At the global level, a comprehensive HDV screening strategy would require only 1,994,000 HDV antibody tests and less than 89,000 HDV PCR tests. Double reflex testing is the preferred strategy in countries with a low prevalence of HBV and those with a high prevalence of both HBV and HDV. For example, in the European Union and North America only 35,000 and 22,000 cases, respectively, will require anti-HDV testing annually.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Razavi HA, Buti M, Terrault NA, et al. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries. J Hepatol. 2023. PMID: 37030400. doi:10.1016/j.jhep.2023.02.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。